Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05843318 · ClinicalTrials.gov registry record · NA

Water Intake and Weight Control in Older Adults

A NA study of Overweight and Obesity, sponsored by Virginia Polytechnic Institute and State University.

Recruiting
Registry status
NA
Development phase
375
Enrollment target
1
Study location

NCT05843318: Recruiting NA study of Overweight and Obesity, sponsored by Virginia Polytechnic Institute and State University.

NCT05843318 is a NA study of Overweight and Obesity that is actively recruiting participants, run by Virginia Polytechnic Institute and State University. The registered enrollment target is 375 participants, above the 225-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (67% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05843318, a NA study of Overweight and Obesity, is actively recruiting participants, sponsored by Virginia Polytechnic Institute and State University.

RECRUITING
Registry status
NA
Development phase
375 participants
Enrollment target
1
Study location

Study Summary

This study is a randomized controlled intervention trial in adults aged 50+ years with overweight or obesity, which will compare three groups with different diet prescriptions: 1) pre-meal water consumption (500 ml, before each main meal) with a hypocaloric diet; 2) 1500 ml water consumed throughout the day with a hypocaloric diet; 3) hypocaloric diet with no instructions regarding water consumption. Smart water bottles will objectively assess water intake timing and volume. Urine osmolality, urine volume, and serum osmolality will be used as objective indicators of compliance with the water intake prescription. We will investigate changes in perceived hunger and fullness and appetite-regulating hormones as potential mechanisms by which premeal water could improve appetite regulation. We will also investigate the impact of water consumption and hydration on executive function capabilities, which may influence intervention adherence. Although increasing water intake could be an effective weight management strategy, no evidence-based recommendations exist for the timing of water intake needed for this benefit.

Primary Outcome

Body weight change in weight loss and weight loss maintenance phases

Conditions Studied

Interventions

  • BEHAVIORAL Water intake and weight control in older adults - Premeal Water + hypocaloric diet
  • BEHAVIORAL Water intake and weight control in older adults - Total Daily Water + hypocaloric diet
  • BEHAVIORAL Water Intake and weight control in older adults - hypocaloric diet alone

Study Locations (1)

Virginia

  • Virginia Tech - Blacksburg

Trial Details

FieldValue
Enrollment Target 375 participants
Start Date 2023-11-13
Est. Completion 2028-03-31
Phase NA

What NCT05843318 shows while recruiting

NCT05843318 is an interventional study that assigns participants to a tested intervention. The registered 375 participants enrollment target is mid-sized for trials with a published cap, above the 225-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (67% higher).

The record links to 1 condition, with Overweight and Obesity appearing as the primary indexed condition, and to 3 interventions - of which Water intake and weight control in older adults - Premeal Water + hypocaloric diet is the first listed.

NCT05843318 reports a single indexed study location in Virginia.

Frequently Asked Questions

What is clinical trial NCT05843318 about?

NCT05843318 is a clinical study titled "Water Intake and Weight Control in Older Adults". This study is a randomized controlled intervention trial in adults aged 50+ years with overweight or obesity, which will compare three groups with different diet prescriptions: 1) pre-meal water consumption (500 ml, before each main meal) with a hypocaloric diet; 2) 1500 ml water consumed throughout...

What is the current status of trial NCT05843318?

This trial is currently recruiting. It is a NA study. The enrollment target is 375 participants. The study started on 2023-11-13. Estimated completion is 2028-03-31.

What conditions does trial NCT05843318 study?

This clinical trial studies the following conditions: Overweight and Obesity.

What interventions are being tested in trial NCT05843318?

The interventions under investigation include: Water intake and weight control in older adults - Premeal Water + hypocaloric diet (BEHAVIORAL), Water intake and weight control in older adults - Total Daily Water + hypocaloric diet (BEHAVIORAL), Water Intake and weight control in older adults - hypocaloric diet alone (BEHAVIORAL).

Who is sponsoring clinical trial NCT05843318?

This trial is sponsored by Virginia Polytechnic Institute and State University, which has 104 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05843318 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Overweight and Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05843318's enrollment target sits among peer trials

375 21st of 115 higher than 95 of 115 other Overweight and Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Overweight and Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03686124 · 375 participants · Phase 1

    ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

  • NCT04059172 · 375 participants · Early Phase 1

    Efficacy of Combined Ibuprofen and Acetaminophen Therapy Versus Ibuprofen Alone Versus Placebo Alone for Pain Management

  • NCT04134923 · 375 participants

    Imaging Biomarkers in Preclinical and Symptomatic AD

  • NCT04569747 · 375 participants · Phase 2

    A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05843318, the US trial registry maintained by the National Library of Medicine. NCT05843318 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.